
Tadalafil is very specific for PDE5 and is also very specific for the enzyme PDE11. Unfortunately, we don’t know much about PDE11, which is found in the heart, in the pituitary gland in the brain and in the testicles.
Pharmacokinetics, half-life, is how long the medication stay s in the blood. This means that vardenafil (Levitra) should act longer than sildenafil (Viagra) but the clinical significance is not known. Tadalafil (Cialis) has the longest half-life and allows you to take the medication and not relate the sexual activity to the immediate use of the medication. The drawback is if you need nitrates after using tadalafil (Cialis), this medication lasts a long time in your blood stream and may place you at a higher risk.
When certain medications such as antidepressants or antihypertensives are suspected of contributing to ED,3 the patient should be advised to talk with the prescribing physician to determine whether alternative medications with better side-effect profiles are available. Beta-blockers are associated with ED, although the etiology is not well established.4 Patient awareness or anxiety regarding ED as a potential side effect of beta-blockers may itself contribute to dissatisfaction with erectile function after starting a beta-blocker. While further study is needed, trying an alternative medication for patients on first-generation (propranolol) or second-generation (metoprolol, atenolol) beta-blockers may be considered. In a review of several small studies, Sharp and Gales5 noted mildly improved or similar sexual function in patients after starting nebivolol, which was attributed to the beta-blocker’s ability to stimulate endothelial release of nitric oxide, producing vasoactive effects and potentiating penile erection. If feasible for the patient, medications like calcium channel blockers, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers can also be explored, as their risk for causing ED is thought to be lower.
Thiazide diuretics at high doses have been associated with adverse effects on erectile function compared with other antihypertensive drugs.6 However, treatment of hypertension should remain the priority, and it may not be clinically appropriate to adjust antihypertensive medications, particularly without strong evidence to support the use of one medication over another. The evidence regarding a correlation between statin medications and ED risk is conflicting. Some studies suggest that statins have sexual side effects, while others propose that the overall cardiovascular benefit of these medications contributes to improved erectile function.7 No large-scale randomized controlled trials have established a link between statins and testosterone levels, and cessation of statin therapy or lowering of statin regimens as a means of improving ED is not recommended. Rather, we suggest optimizing well-established contributing factors such as cardiovascular fitness and testosterone levels. Despite making lifestyle changes, many patients with ED require PDE5 inhibitors such as sildenafil or tadalafil to improve erectile function. Younger people might do well treated with tadalafil, (Cialis) while older people with other health issues might be better off using sildenafil (Viagra) or vardenafil (Levitra) but more data are needed. The side effects of vardenafil (Levitra) are potentially less than sildenafil (Viagra), but more data are needed. In a recent study on men with erectile dysfunction and diabetes, vardenafil (Levitra) improved their erectile dysfunction. Tadalafil (Cialis) is as effective as sildenafil (Viagra), and vardenafil (Levitra) with similar side effects except for back pain that occurs occasionally with tadalafil, probably because of the long half-life. Many people stop taking drugs because they are experiencing side effects, they no longer have a partner, or they are worried about safety. Sexual activity is not a major contributor to the risk of a heart attack.
| Alternative Type | Possible Risks | Contraindications | Notes |
|---|---|---|---|
| Natural Supplements | Interactions with medications, inconsistent dosage | Heart disease, hypertension, pregnancy | Consult healthcare provider before use |
| Off-label Medications | Unknown long-term effects, unregulated | Use without medical supervision | Increased risk of adverse effects |
| Lifestyle Modifications | Minimal risks, but slow results | N/A | Should be combined with other methods |
| Unapproved Medications | Potential contamination, side effects | Lack of regulation, no approval | High caution recommended |
Sexual activity, with or without sildenafil (Viagra) increases the chance of an MI during sexual activity by only 0.1%.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 60mg | 180 + 10 Pills | 313.11€ 298.20€ | |
| Cialis Soft Tabs | 20mg | 120 + 6 Pills | 248.64€ 236.80€ | |
| Cialis Generic | 2.5mg | 120 + 6 Pills | 128.93€ 122.79€ | |
| Cialis Original | 20mg | 92 + 4 Pills | 377.99€ 359.99€ | |
| Cialis Original | 20mg | 22 + 2 Pills | 129.20€ 123.05€ | |
| Cialis Professional | 20mg | 180 + 4 Pills | 423.11€ 402.96€ | |
| Cialis Black | 80mg | 10 Pills | 43.27€ 41.21€ | |
| Cialis Generic | 60mg | 90 + 6 Pills | 196.67€ 187.30€ | |
| Cialis Super Active | 20mg | 60 + 8 Pills | 230.32€ 219.35€ | |
| Cialis Original | 20mg | 76 + 4 Pills | 319.19€ 303.99€ | |
| Cialis Black | 80mg | 20 Pills | 71.83€ 68.41€ | |
| Cialis Generic | 5mg | 20 Pills | 41.99€ 39.99€ | |
| Cialis Generic | 2.5mg | 360 + 10 Pills | 260.03€ 247.65€ | |
| Cialis Professional | 20mg | 20 Pills | 78.33€ 74.60€ |
If pills fail, there are vacuum devices, Muse, injections, bypass surgery and implants. The patient making a presentation has had penile bypass surgery.
Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Editor’s note: This article was originally published in the Cleveland Clinic Journal of Medicine A 68-year-old man with diabetes, hypertension, and hyperlipidemia is experiencing unsatisfactory results with maximum doses of sildenafil (100 mg) canadian pharmace cialis and tadalafil (20 mg) for erectile dysfunction. You confirm he is taking his medication as directed. What are the next options for him?
Erectile dysfunction (ED), which affects 70% of men over 70 and more than 150 million men worldwide, is defined as a persistent inability to attain or sustain an erection suitable for sexual intercourse.1 Phosphodiesterase type 5 (PDE5) inhibitors are first-line medical treatment for ED,1 but up to 40% of patients do not have a satisfactory response to these agents.2 Alternative therapies for patients who do not respond to PDE5 inhibitors or who experience intolerable side effects from them include intracavernosal injection, vacuum erection devices, and penile prosthesis implantation. Before medical therapy for ED is tried, it is crucial to address modifiable risk factors, counsel patients on lifestyle modifications, and identify any medications or underlying medical conditions contributing to ED. Risk factors for ED include smoking, obesity, cardiovascular disease, depression, prostate surgery, penile trauma, obstructive sleep apnea, and testosterone deficiency. Lifestyle adjustments such as weight loss, increased cardiovascular exercise, reduced alcohol intake, and quitting smoking can partially alleviate symptoms.1 Also, a thorough history should explore psychological, psychosocial, and relational factors and sexual practices that may be impacting sexual performance, and referral to a sex therapist should be considered. A diagnosis of ED can indicate the presence of systemic disease or reversible causes like medication side effects or testosterone deficiency (discussed below). In addition he takes testosterone and sildenafil as needed.
Tadalafil is very specific for PDE5 and is also very specific for the enzyme PDE11. Unfortunately, we don’t know much about PDE11, which is found in the heart, in the pituitary gland in the brain and in the testicles. Pharmacokinetics, half-life, is how long the medication stay s in the blood. This means that vardenafil (Levitra) should act longer than sildenafil (Viagra) but the clinical significance is not known. Tadalafil (Cialis) has the longest half-life and allows you to take the medication and not relate the sexual activity to the immediate use of the medication.
The drawback is if you need nitrates after using tadalafil (Cialis), this medication lasts a long time in your blood stream and may place you at a higher risk. Younger people might do well treated with tadalafil, (Cialis) while older people with other health issues might be better off using sildenafil (Viagra) or vardenafil (Levitra) but more data are needed. The side effects of vardenafil (Levitra) are potentially less than sildenafil (Viagra), but more data are needed. In a recent study on men with erectile dysfunction and diabetes, vardenafil (Levitra) improved their erectile dysfunction. Tadalafil (Cialis) is as effective as sildenafil (Viagra), and vardenafil (Levitra) with similar side effects except for back pain that occurs occasionally with tadalafil, probably because of the long half-life. This is a classic example of why people with ED need complete care: a psychological exam, history and physical exam, and diagnostic studies with long term follow-up care.
Patients with ED should not just be prescribed sildenafil (Viagra) and then be lost to follow-up. Urologists offer alternative therapies for patients who do not respond to PDE5 inhibitors or who experience intolerable side effects Image content: This image is available to view online. By Vivian Hua, BA; Bradley Roth, BS; Andrew Shumaker, MD; Raevti Bole, MD; and Petar Bajic, MD Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Editor’s note: This article was originally published in the Cleveland Clinic Journal of Medicine A 68-year-old man with diabetes, hypertension, and hyperlipidemia is experiencing unsatisfactory results with maximum doses of sildenafil (100 mg) canadian pharmace cialis and tadalafil (20 mg) for erectile dysfunction. You confirm he is taking his medication as directed. What are the next options for him? Erectile dysfunction (ED), which affects 70% of men over 70 and more than 150 million men worldwide, is defined as a persistent inability to attain or sustain an erection suitable for sexual intercourse.1 Phosphodiesterase type 5 (PDE5) inhibitors are first-line medical treatment for ED,1 but up to 40% of patients do not have a satisfactory response to these agents.2 Alternative therapies for patients who do not respond to PDE5 inhibitors or who experience intolerable side effects from them include intracavernosal injection, vacuum erection devices, and penile prosthesis implantation. Before medical therapy for ED is tried, it is crucial to address modifiable risk factors, counsel patients on lifestyle modifications, and identify any medications or underlying medical conditions contributing to ED. Risk factors for ED include smoking, obesity, cardiovascular disease, depression, prostate surgery, penile trauma, obstructive sleep apnea, and testosterone deficiency.
Many people stop taking drugs because they are experiencing side effects, they no longer have a partner, or they are worried about safety. Sexual activity is not a major contributor to the risk of a heart attack. Sexual activity, with or without sildenafil (Viagra) increases the chance of an MI during sexual activity by only 0.1%. If pills fail, there are vacuum devices, Muse, injections, bypass surgery and implants. The patient making a presentation has had penile bypass surgery.
In addition he takes testosterone and sildenafil as needed. This is a classic example of why people with ED need complete care: a psychological exam, history and physical exam, and diagnostic studies with long term follow-up care. Patients with ED should not just be prescribed sildenafil (Viagra) and then be lost to follow-up. Urologists offer alternative therapies for patients who do not respond to PDE5 inhibitors or who experience intolerable side effects Image content: This image is available to view online. By Vivian Hua, BA; Bradley Roth, BS; Andrew Shumaker, MD; Raevti Bole, MD; and Petar Bajic, MD Cleveland Clinic is a non-profit academic medical center. Lifestyle adjustments such as weight loss, increased cardiovascular exercise, reduced alcohol intake, and quitting smoking can partially alleviate symptoms.1 Also, a thorough history should explore psychological, psychosocial, and relational factors and sexual practices that may be impacting sexual performance, and referral to a sex therapist should be considered.
These agents promote erections by increasing nitric oxide levels and blocking the decomposition of cyclic guanosine monophosphate, thereby relaxing the smooth muscle within the corpora cavernosa and increasing blood flow.1 However, PDE5 inhibitors are efficacious in only 60% to 70% of patients.2 When starting PDE5 inhibitors, proper administration should be ensured, as a large proportion of treatment failures with these agents is attributed to incorrect use.2 Sildenafil should be taken 30 to 60 minutes before intercourse on an empty stomach. The recommended window for taking on-demand tadalafil, which is not impacted by food intake, is 30 to 120 minutes before intercourse, but for optimal effectiveness, it should be taken 60 to 120 minutes before intercourse.8 Daily low-dose tadalafil (5 mg) may be considered for men who also experience voiding dysfunction due to prostate enlargement or men with mild ED. Patients taking 5-alpha-reductase inhibitors for benign prostatic hyperplasia who also experience ED and low libido should be referred to a urologist for alternative management strategies such as daily low-dose tadalafil, alpha-blockers, or minimally invasive surgical therapies. In fact, some selective alpha-blockers have been found to preserve or improve erectile function.9 Combination therapy with daily tadalafil plus on-demand higher-dose tadalafil or sildenafil may be considered.10 Before determining that the medication has failed to achieve the desired result, several trials of PDE5 inhibitors with at least 24 hours between doses should be attempted.11 Additionally, other reversible causes of ED, such as testosterone deficiency, should be assessed. An early morning testosterone level (before 11:00 am) can identify testosterone deficiency in the presence of symptoms or signs of low testosterone such as low libido, fatigue, and loss of body hair.10 Testosterone levels less than 300 ng/dL with these accompanying symptoms may warrant treatment with testosterone replacement therapy, which placebo-controlled randomized trials and meta-analyses have demonstrated may help improve erectile function and libido.10–12 However, patients with ED but no symptoms of testosterone deficiency are less likely to benefit from replacement therapy.
Assessment of testosterone deficiency is most valuable in men with borderline response to PDE5 inhibitors and with other signs and symptoms of low testosterone. Once these avenues have been exhausted, exploring alternative therapies that aid in restoring erectile function should be considered. Therapeutic options beyond PDE5 inhibitors include intracavernosal injection therapy, vacuum erection devices, and penile prostheses.1,2,11 These alternatives are typically used when the patient does not respond to PDE5 inhibitors or experiences intolerable side effects (e.g., headache, flushing, dyspepsia, visual disturbances, backache) from them. Treatment should be based on patient and partner preferences, comorbidities, and current medications.2 The 2018 American Urological Association guideline on ED11 emphasizes the importance of shared decision-making between patient and physician. A diagnosis of ED can indicate the presence of systemic disease or reversible causes like medication side effects or testosterone deficiency (discussed below). When certain medications such as antidepressants or antihypertensives are suspected of contributing to ED,3 the patient should be advised to talk with the prescribing physician to determine whether alternative medications with better side-effect profiles are available. Beta-blockers are associated with ED, although the etiology is not well established.4 Patient awareness or anxiety regarding ED as a potential side effect of beta-blockers may itself contribute to dissatisfaction with erectile function after starting a beta-blocker. While further study is needed, trying an alternative medication for patients on first-generation (propranolol) or second-generation (metoprolol, atenolol) beta-blockers may be considered. In a review of several small studies, Sharp and Gales5 noted mildly improved or similar sexual function in patients after starting nebivolol, which was attributed to the beta-blocker’s ability to stimulate endothelial release of nitric oxide, producing vasoactive effects and potentiating penile erection. If feasible for the patient, medications like calcium channel blockers, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers can also be explored, as their risk for causing ED is thought to be lower. Thiazide diuretics at high doses have been associated with adverse effects on erectile function compared with other antihypertensive drugs.6 However, treatment of hypertension should remain the priority, and it may not be clinically appropriate to adjust antihypertensive medications, particularly without strong evidence to support the use of one medication over another.
| Brand Name | Active Ingredient | Price Range (per tablet) | Available Forms | Approval Status |
|---|---|---|---|---|
| Stendra (avanafil) | Avanafil | $10–$15 | Tablets | FDA-approved |
| Kamagra | Sildenafil citrate | $1–3 (generics) | Oral tablets | Not FDA-approved |
| Vidalista | Tadalafil | $2–4 | Tablets | Approved in some countries |
| Super P-Force | Sildenafil + Dapoxetine | $3–5 | Chewable tablets | Unregulated in some markets |
The evidence regarding a correlation between statin medications and ED risk is conflicting.
Some studies suggest that statins have sexual side effects, while others propose that the overall cardiovascular benefit of these medications contributes to improved erectile function.7 No large-scale randomized controlled trials have established a link between statins and testosterone levels, and cessation of statin therapy or lowering of statin regimens as a means of improving ED is not recommended. Rather, we suggest optimizing well-established contributing factors such as cardiovascular fitness and testosterone levels. Despite making lifestyle changes, many patients with ED require PDE5 inhibitors such as sildenafil or tadalafil to improve erectile function. These agents promote erections by increasing nitric oxide levels and blocking the decomposition of cyclic guanosine monophosphate, thereby relaxing the smooth muscle within the corpora cavernosa and increasing blood flow.1 However, PDE5 inhibitors are efficacious in only 60% to 70% of patients.2 When starting PDE5 inhibitors, proper administration should be ensured, as a large proportion of treatment failures with these agents is attributed to incorrect use.2 Sildenafil should be taken 30 to 60 minutes before intercourse on an empty stomach.
| Medication | Active Substance | Onset of Action | Duration of Effect | Common Side Effects | Special Notes |
|---|---|---|---|---|---|
| Cialis (Tadalafil) | Tadalafil | 30–60 min | Up to 36 hours | Headache, flushing, back pain | Food does not affect absorption |
| Viagra (Sildenafil) | Sildenafil | 30–60 min | 4–6 hours | Visual disturbances, headache | Taken on an empty stomach |
| Levitra (Vardenafil) | Vardenafil | 30–60 min | 4–5 hours | Dizziness, flushing | More effective with high-fat meals |
The recommended window for taking on-demand tadalafil, which is not impacted by food intake, is 30 to 120 minutes before intercourse, but for optimal effectiveness, it should be taken 60 to 120 minutes before intercourse.8 Daily low-dose tadalafil (5 mg) may be considered for men who also experience voiding dysfunction due to prostate enlargement or men with mild ED. Patients taking 5-alpha-reductase inhibitors for benign prostatic hyperplasia who also experience ED and low libido should be referred to a urologist for alternative management strategies such as daily low-dose tadalafil, alpha-blockers, or minimally invasive surgical therapies. In fact, some selective alpha-blockers have been found to preserve or improve erectile function.9 Combination therapy with daily tadalafil plus on-demand higher-dose tadalafil or sildenafil may be considered.10 Before determining that the medication has failed to achieve the desired result, several trials of PDE5 inhibitors with at least 24 hours between doses should be attempted.11 Additionally, other reversible causes of ED, such as testosterone deficiency, should be assessed. An early morning testosterone level (before 11:00 am) can identify testosterone deficiency in the presence of symptoms or signs of low testosterone such as low libido, fatigue, and loss of body hair.10 Testosterone levels less than 300 ng/dL with these accompanying symptoms may warrant treatment with testosterone replacement therapy, which placebo-controlled randomized trials and meta-analyses have demonstrated may help improve erectile function and libido.10–12 However, patients with ED but no symptoms of testosterone deficiency are less likely to benefit from replacement therapy.
Assessment of testosterone deficiency is most valuable in men with borderline response to PDE5 inhibitors and with other signs and symptoms of low testosterone.
Once these avenues have been exhausted, exploring alternative therapies that aid in restoring erectile function should be considered. Therapeutic options beyond PDE5 inhibitors include intracavernosal injection therapy, vacuum erection devices, and penile prostheses.1,2,11 These alternatives are typically used when the patient does not respond to PDE5 inhibitors or experiences intolerable side effects (e.g., headache, flushing, dyspepsia, visual disturbances, backache) from them. Treatment should be based on patient and partner preferences, comorbidities, and current medications.2 The 2018 American Urological Association guideline on ED11 emphasizes the importance of shared decision-making between patient and physician.